< Back to scientific publications

Magazine 9.54

Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First ItalianųoRk Study (BRIVAFIRST).

Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Irelli EC, Chiesa V, Dainese F, De Maria G, Didato G, Gennaro GD, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group Membership

Date: 2022

Scope of interest: Epilepsy




You may also be interested in:

Magazine 2.3

The role of teicoplanin in the treatment of SARS-CoV-2 infection: A retrospective study in critically ill COVID-19 patients (Tei-COVID study).

Authors: Ceccarelli G et al

Date: jul 21

Scope of interest: infectious disease


Read details
Report/Poster of Convention/Congress Act

Prevention of HIV disease in prison: the results of the project “Free you live well with HIV in Prison-FLEW HIV

Authors: Dell 'Isola

Date: 2017

Scope of interest: Prison health


Read details
Report/Poster of Convention/Congress Act

Chronic liver diseases in the prison population

Authors: Dell 'Isola

Date: 2012

Scope of interest: prison health


Read details